Spinal Cord Lesions

Drug	Drug Name	Drug Description
DB00108	Natalizumab	A monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis.

Drug	Drug Name	Target	Type
DB00108	Natalizumab	Integrin alpha-4	target
DB00108	Natalizumab	Low affinity immunoglobulin gamma Fc region receptor III-B	target
DB00108	Natalizumab	High affinity immunoglobulin gamma Fc receptor I	target
DB00108	Natalizumab	Intercellular adhesion molecule 1	target

Drug	Drug Name	Phase	Status	Count